The protein tyrosine phosphatase family comprises transmembrane receptor-like and cytosolic forms. Although the exact biological functions of these enzymes are largely unknown, they are believed to counter-balance the effects of protein tyrosine kinases. We have previously identified and characterized a mammalian transmembrane protein tyrosine phosphatase, called LAR (leukocyte common antigen related gene), whose expression is often associated with proliferating epithelial cells or epithelial progenitor cells. This study investigates the potential role of LAR in the regulation of cell growth and death in mammals.
Background
Signal transduction involving protein tyrosine phosphorylation cascades is a fundamental cellular mechanism regulating cell survival, growth, differentiation and migration. The tyrosine phosphorylation status of a protein is controlled by two antagonistic families of enzymes, protein tyrosine kinases, which add phosphate, and protein tyrosine phosphatases, which remove phosphate. The protein tyrosine kinases, which were originally discovered as biologically important molecules such as retroviral oncoproteins and growth factor receptors, have been studied extensively during the past two decades and their significance in cellular physiology is widely appreciated. The protein tyrosine phosphatases, on the other hand, were mostly identified based on their sequence homology to pre-existing tyrosine phosphatases that were defined by their enzymatic activities in vitro. In comparison with the tyrosine kinases therefore, the tyrosine phosphatases are much less well studied and their biological functions are poorly understood.
LAR is a member of a family of transmembrane, receptorlike protein tyrosine phosphatases or PTPs [1] [2] [3] [4] , originally identified by sequence homology to the leukocyte common antigen CD45 [1] . LAR expression is detected in a wide variety of tissues and is regulated during development [5] . In cultured cells, the levels of LAR mRNA and protein are influenced by growth factors and cell density [6, 7] . Structural and biochemical characterization of LAR suggest that it might participate in transmembrane signaling involving protein tyrosine phosphorylation by counterbalancing the activity of the protein tyrosine kinases [1, 2] .
Functional studies of LAR in cultured cells suggest that it might have a role in regulating signal transduction mediated by receptor tyrosine kinases [8] [9] [10] [11] [12] . Attempts to find physiological substrates of LAR using interaction-trap strategies identified two proteins that physically interact with LAR: one colocalized with LAR at focal adhesions of human breast adenocarcinoma cells [13] and the other contained guanine nucleotide exchange factor domains of the Rac/Rho family of GTPases [14] , suggesting that LAR may also function in regulating cell adhesion, migration and/or signaling mediated by the focal adhesion complex. There is also evidence that the Drosophila homolog of LAR, DLAR, is selectively expressed in central nervous system and is required for motor axon guidance during embryonic development, presumably by regulating cell adhesion [15, 16] . Taken together, these observations suggest that LAR might be a multifunctional protein and have roles in diverse aspects of cell physiology involving regulation of protein tyrosine phosphorylation.
Programed cell death or apoptosis is a fundamental part of tissue homeostasis during normal development and in pathological conditions [17] . The cell death machinery is regulated by both internal genetic programs and external physiological stimuli. Studies of the molecular pathways, mechanisms and regulation of the cell death process have revealed three gene families that are the central components of apoptotic pathways: the tumor necrosis factor (TNF) family and their receptors [18] , the interleukin-1 β-converting enzyme (ICE) or caspase family of cysteine proteases [19] and the proto-oncogenes of the bcl-2 gene family [20] . At the same time, a large number of molecules, which normally function in directing cell proliferation and differentiation, have been found to be involved in regulating apoptotic pathways [21] .
Protein tyrosine phosphorylation and tyrosine kinases have been implicated as playing critical roles in regulating cell survival. For example, in addition to its ability to promote cell proliferation and differentiation, the basic fibroblast growth factor (bFGF), by activating tyrosine kinase activity of its receptor, is a potent suppressor of programed cell death during development of the limb bud [22] , lens fibre cells in the mouse [23] , and during TNFα-induced apoptosis [24] . Insulin and insulin-like growth factor (IGF) are effective inhibitors of apoptosis induced by trophic factor removal [25] and overexpression of c-Myc [26] or ICE [27] . Activation of survival pathways that involve insulin and IGF has been hypothesized to be mediated by tyrosine phosphorylation activity of the insulin and IGF receptors and by phosphatidylinositol 3-kinase [28, 29] . These results suggest that tyrosine phosphorylation of certain proteins is critical for cell survival. The involvement of PTPs in cell-death control has been suggested by a number of experiments using tyrosine phosphatase inhibitors [30, 31] , in which apoptosis was found to be inhibited following inactivation of tyrosine phosphatases. The exact roles of tyrosine phosphatases in these experiments and in cell-death control in general, are however not clear.
To define the biological functions of LAR and to investigate the potential role of PTPs in regulating cell growth, death and differentiation, we overexpressed LAR in various mammalian cell lines. We found that overexpression of LAR in many types of cells, especially nontransformed cells, was cytotoxic. Using an inducible expression system, we demonstrated that overexpression of LAR activated the caspase pathway and induced apoptosis. Our results suggest that, in mammalian cells, LAR and LARlike PTPs might play a role in regulating tyrosine phosphorylation of a set of proteins which are critical for cell growth and survival. These proteins are important because they might function to link signal transduction pathways involving protein phosphorylation cascades with the caspase-mediated cell-death pathway. Our study provides an assay system to search for these proteins. This is the first demonstration of the involvement of a receptor-like PTPs in the regulaton of cell death.
Results

Cells overexpressing wild-type LAR are negatively selected
To investigate possible roles of LAR in signal transduction and regulation of cell growth, we attempted to alter LAR activity by overexpressing wild-type and mutant LAR in cultured cells. Two expression constructs were generated, one encoding the full-length wild-type LAR, and the other encoding only the extracellular domain of LAR ( Figure 1) . The two constructs were tested in COS-7 cells by transient transfection followed by immunoprecipitation assays. Both proteins were expressed at comparable levels in COS-7 cells (Figure 2 ). Cells transfected with the wild-type LAR cDNA expressed three protein species, a 190 kDa precursor, a 145 kDa proteolytically cleaved extracellular domain subunit and a 85 kDa intracellular 248 Current Biology, Vol 8 No 5
Figure 1
The full-length wild-type LAR and the truncated LAR mutant, LAR-∆TP, which contains only the extracellular domain of LAR. The full-length LAR has an extracellular portion composed of immunoglobulin-like domains and fibronectin type III repeats and an intracellular portion containing two tandemly repeated phosphatase domains. Notice that the LAR protein is cleaved into two subunits which remain associated by a non-covalent linkage [2] . phosphatase-domain-containing subunit [2] . Cells transfected with the truncated LAR cDNA, on the other hand, expressed only the 145 kDa subunit (Figure 2 ).
We next tried to establish stable cell clones that overproduce LAR. We introduced the two cDNA expression constructs by transfection into a rat embryonic fibroblast cell line 208F, from which the rat LAR cDNA was previously isolated and in which the LAR protein was characterized [2] . Although we could obtain drug-resistant colonies from both transfections, the number of colonies obtained from the cells transfected with wild-type LAR was consistently less than the number obtained with the truncated LAR (data not shown). Furthermore, most of the clones that were transfected with wild-type LAR showed either no increase or less than onefold increase in LAR protein level when analyzed by western blotting or by immunoprecipitation ( Figure 3 and data not shown). The few LAR-expressing clones, obtained from transfections with the wild-type LAR, expressed aberrant forms of the protein (Figure 3 and data not shown). In contrast, more than 50% of the clones transfected with the truncated LAR cDNA expressed 5-10-fold higher levels of the mutant LAR protein over those of the endogenous LAR protein (Figure 3 and data not shown). It appeared that overexpression of wild-type LAR in rat fibroblasts had negative effects on cell growth, resulting in negative selection against cells overexpressing the LAR protein. The only cells which could grow after transfection were the cells which had no increase or very small increases in LAR expression or expressed aberrant forms of the LAR protein. Overexpression of truncated LAR did not affect cell morphology, growth or protein tyrosine phosphorylation (data not shown).
Overexpression of LAR induces cell death
To understand the reason for the failure to obtain stable transfectants that overproduce wild-type LAR, we transiently co-transfected the 208F cells with an indicator plasmid encoding the Escherichia coli β-galactosidase protein, together with either of the two LAR expression plasmids. As controls, we co-transfected the cells with the vector plasmid or with a plasmid expressing ICE, which is known to induce apoptosis when overexpressed in rat fibroblast cells [32] .
The number and the morphology of the transfected cells were analyzed 24 hours after transfection. As shown in Western blot analysis of LAR expression in stable transfectants. Rat fibroblast 208F cells were transfected with the wild-type LAR or the truncated LAR-∆TP. After selection, stably transfected clones were isolated. Equal amounts of total protein from the isolated clones were analyzed by western blotting using anti-LAR antiserum αN-131, which recognizes only the 145 kDa extracellular subunit of LAR (arrowheads). Protein samples are numbered according to the isolated clones. Notice that, in lanes 10 and 11 for the wild-type LAR transfection, two aberrant LAR proteins were expressed. To verify that overexpression of LAR indeed induced cell death, we expressed LAR under the control of the tetracycline-suppressible promoter [33] . Our initial efforts to use the fibroblast cell line 208F for the tetracycline expression system failed because of the leaky activity of the tetracycline-suppressible promoter in this cell line. We then selected an osteosarcoma cell line U2OS, with which the Tet-suppressible system has been successfully used (L Zhu, personal communication).
Constructs expressing either wild-type or truncated LAR were transfected into U2OS cells and stable cell clones, which could be induced to express the two proteins, were established. In general, comparable amounts of LAR protein were induced in the two sets of transfectants. To understand the molecular basis of the LAR-induced cell death, we investigated the involvement of several key molecules that have been implicated as playing key roles in apoptotic processes. The requirement for functional p53 in LAR-induced cell death was investigated by introducing the LAR expression construct into another osteosarcoma cell line, Saos2, in which the p53 gene was deleted. Although the LAR protein level induced in the Saos2 cells was not as high as in the U2OS cells (data not shown), LAR induced similar apoptotic cell death in these p53-deficient cells (Figure 7) , indicating that p53 is not required for LARinduced apoptosis.
To investigate the involvement of caspases in LAR-induced death, we induced LAR expression in the presence of caspase inhibitors. LAR-induced cell death was inhibited by ZVAD, a modified peptide which inhibits several caspases [34] , in a dose-dependent manner (Figure 8 and data not shown). At a concentration of 50 µM, ZVAD completely inhibited cell death as well as cell detachment (Figure 8a,b) , suggesting that cell detachment may be a consequence of caspase activation. ZVAD had no apparent effect on uninduced cells (Figure 8a) . We next determined which member of the caspase family was required for the LARinduced cell death using specific caspase inhibitors. Cell death was partially inhibited by the caspase-3 inhibitor ZDEVD but not by the ICE inhibitor ZYVAD (Figure 8b ). Because ZVAD is more effective than ZDEVD, our data suggest that LAR may induce apoptosis partly through activation of caspase-3, but other caspases may also be involved.
Caspase-3, but not ICE, is activated during LAR-induced cell death
To confirm the above suggestion, we examined the proteolytic activation of ICE and caspase-3 [35, 36] 
Figure 5
Cell death induced by overexpression of LAR under the control of the tetracycline-suppressible promoter. (a) Induction of LAR overexpression. Clones of U2OS cells containing the tetracyclinesuppressible LAR cDNA expression constructs were induced to express LAR by removing tetracycline from the medium. Cells, which were stably transfected with the wild-type LAR construct (U2OS/LAR) or the truncated LAR construct (U2OS/LAR-∆TP), were cultured in the presence (Tet+) or absence (Tet-) of tetracycline for 24 h. Three independent clones of cells were used for each LAR construct. Equal amounts of total protein from these cells were analyzed by western blotting using anti-LAR antiserum αN-130, which recognizes the 190 kDa precursor and the 145 kDa extracellular subunit of LAR. Parental U2OS cells was used as a control. overexpression with LAR. We also investigated whether poly(ADP-ribose) polymerase (PARP), a known substrate of caspases was cleaved [36] . Cells were collected at different time points after induction of LAR overexpression. Cell lysates were analyzed by western blot analysis using specific antibodies against ICE, caspase-3 and PARP. Both caspase-3 and PARP were cleaved in the LAR-overexpressing cells but not in the control cells ( Figure 9 ). The level of ICE protein, on the other hand, was not affected by LAR overexpression (Figure 9 ), indicating that caspase-3, but not ICE, was activated upon LAR overexpression and might be the protease responsible for LAR-induced apoptosis.
Overexpression of LAR does not affect cell adhesion
Activation of caspases has been shown to occur during anoikis, a form of apoptosis caused by detachment of cells from their substratum [37] . The structure of the LAR extracellular domain suggests that LAR might interact with extracellular matrix proteins and it is therefore possible that overexpression of LAR might interfere with cell adhesion. LAR-induced cell death could have been caused by disrupted cell adhesion and the cells could have died through anoikis. Nevertheless, the observation that both cell death and cell detachment were inhibited by caspase inhibitors (Figure 8 ) suggested that LARinduced cell death might not be a consequence of disrupted cell adhesion. We therefore investigated effects of LAR overexpression on cell adhesion. Uninduced cells and cells induced to express LAR for 8-24 hours were plated onto microtiter plates coated with various concentrations of fibronectin. Adherent cells were examined after incubation for 30 minutes. No obvious changes in cell adhesion to fibronectin were observed following induction of LAR overexpression ( Figure 10 and data not shown). Similar results were obtained when laminin or collagen were used as substrates (data not shown). We also tested whether the parental U2OS cells could undergo anoikis by plating the cells onto poly(2-hydroxyethyl methacrylate), which prevents cell attachment [38] . The cells were stained with propidium iodide after incubation for 24 hours. No significant cell death was detected during this period (data not shown). In contrast, LAR-induced cell death occurred less than 12 hours after 
Discussion
We have demonstrated here that overexpression of LAR activates caspase-3 and induces apoptosis, raising the intriguing possibility that LAR might play a role in regulating growth/survival signals and controlling cell death/survival in vivo. The ability of LAR to induce apoptosis requires its phosphatase domain -a truncated version of LAR lacking the catalytic domain does not induce apoptosis and the overexpression of this mutant is well-tolerated by the cells, suggesting that overproduction of the LAR protein per se is not sufficient to cause cell death. We believe that dephosphorylation of certain tyrosine phosphorylated proteins by increased LAR phosphatase activity is the key to caspase activation and induction of cell death. Although the direct substrates of LAR have yet to be identified, we present evidence to suggest that LAR may activate the caspases directly to induce apoptosis. How might overexpression or activation of LAR induce apoptosis? There are at least three possible ways. The first possible mechanism comes from the finding that tyrosine phosphorylation is critical for signal transduction of many important growth factors, such as the platelet-derived growth factor (PDGF), the epidermal growth factor (EGF), the fibroblast growth factor (FGF) and IGF. It has been reported that LAR might directly dephosphorylate the insulin receptor [11] and that LAR modulates signal transduction from a number of growth factor receptor tyrosine kinases [9] . We observed that LAR-induced cell death can be partially inhibited by basic FGF (our unpublished observations), suggesting at least that activation of some receptor tyrosine kinases can overcome the cell death caused by overexpression or activation of the LAR tyrosine phosphatase. Therefore, LAR might dephosphorylate one or several of the growth factor receptors or their downstream signaling components and thus block growth and/or survival signals, which might lead to activation of caspase and induction of cell death [39] .
Second, cell adhesion and signal transduction mediated by cell-adhesion molecules are also critical for cell survival [40] [41] [42] [43] . Mutation of DLAR results in defects in axonal guidance, suggesting that DLAR is involved in cell-cell or cell-matrix signaling and/or adhesion [16] . Serra-Pages et al. [13] reported that the LAR protein is localized at focal adhesions. It is thus possible that the LAR phosphatase has a role in regulating cell adhesion and/or signal transduction mediated by cell-adhesion molecules. Because disruption of cell adhesion during anoikis causes activation of caspases [37, 44, 45] , cell death could occur as a result. Our data, however, show that LAR overexpression has no effect on cell adhesion and that LAR-induced cell death and cell detachment are inhibited by caspase inhibitors. It is therefore unlikely that LAR induces cell death by interfering with cell adhesion. Nevertheless, our data does not exclude the possibility that LAR affects signal transduction mediated by cell-adhesion molecules. This might limit growth signals or create conflicting signals through the focal adhesion complexes, with apoptosis as the consequence.
Last but not least, LAR might activate caspases and cause cell to die through a novel mechanism. Yang et al. [46] have reported that loss of substrate attachment and apoptosis of endothelial cells following removal of growth factors are associated with dephosphorylation of tyrosine residues at the cell periphery. The dephosphorylation of total cellular proteins that accompanies apoptosis can be blocked by orthovanadate, an inhibitor of PTPs [46, 47] .
Orthovanadate has also been found to block DNA fragmentation, a hallmark of apoptosis [48] , and is as effective as basic FGF in preventing the apoptosis of endothelial cells that results from treatment with TNFα [49] . Thus, phosphorylation of certain proteins on tyrosine residues is likely to be important for cell survival. We hypothesize that LAR overexpression leads to dephosphorylation of protein(s) that are critical for cell survival resulting in cell death and cell detachment.
Our data also suggest that LAR-induced apoptosis does not require functional p53. In apoptosis that is induced by DNA damage, p53 plays a critical role [50] but in other cases of apoptosis induced, for example, by glucocorticoids or phorbol ester, p53 is not required, indicating that both p53-dependent and p53-independent apoptotic pathways exist [51, 52] . Our results provide another example of apoptosis that is p53-independent and not induced by DNA damage. We have also analyzed possible effects of LAR on cell-cycle progression prior to cell death and found no evidence indicating that LAR overexpression causes cells to arrest at a particular phase of the cell cycle (our unpublished observations). Thus, LAR-induced cell death might not be a consequence of deregulated cellcycle progression.
Conclusions
The present study provides the first evidence of the involvement of a receptor-like PTP in regulating cell death. Our results show that, when overexpressed, LAR can activate the caspase pathway directly, without affecting cell adhesion, and can induce p53-independent apoptosis. We believe that overexpression of LAR increases the total activity of LAR, resulting in dephosphorylation of a set of proteins which are crucial for cell survival. This study provides a foundation for identifying these important molecules and to link protein tyrosine phosphorylation with the caspase protease pathway.
Materials and methods
Plasmid construction and transfection
Two mammalian cell expression vectors, pBabe [53] , which expresses inserted genes from the constitutive moloney murine leukemia virus long terminal repeat (LTR) promoter, and pUHD10-3 [33] , which contains a tetracycline-suppressible promoter, were used to generate the two sets of LAR expression constructs. The wild-type LAR cDNA expression constructs were generated by ligating a 6.3 kb SalI-BamHI fragment, which contains the 240 bp 5′ untranslated region (UTR), the entire 5661 bp protein-coding region, and the 450 bp 3′ UTR of the rat LAR cDNA [2] , into the two expression vectors. LAR-∆TP constructs were generated by ligating a 3.8 kb SalI-SacI LAR cDNA fragment, which contains the same 5′ UTR followed by 3524 bp of protein coding sequences, into the same expression vectors. Cell transfections were done using the standard calcium phosphate precipitation method [54] . ICE cDNA expression plasmids. The cells were fixed for β-galactosidase staining 24 h after transfection. To generate stable 208F, U2OS, and Saos2 transfectants, the cells were transfected with 2.5 µg plasmid DNA per 5 × 10 4 cells on a 35 mm plate. The cells were diluted into 100 mm plates 12 h after transfection and were selected in the presence of puromycin (Sigma) at 1 µg/ml for 1 week. The individual clones were then isolated and propagated. The U2OS and Saos2 transfectant cell clones were maintained in 10% FBS/DMEM with 250 µg/ml Geneticin (GIBCO), 0.2 µg/ml puromycin (Sigma), and 1 µg/ml tetracycline.
Cells cultures
The rat embryonic fibroblast cell line 208F [55] and the COS-7 cells were grown in 10% CF (GIBCO)/DMEM (GIBCO). The two human osteosarcoma cell lines U2OS and Saos2, which were stably transfected with the tetracycline-controlled transactivator expression plasmid pUHD15-1 [33] , were gifts from Liang Zhu and were maintained in 10% FBS/DMEM (GIBCO) with 250 µg/ml Geneticin (GIBCO).
β-Galactosidase staining
Cells were fixed with 0.5% glutaraldehyde/PBS for 10 min at room temperature, washed 3 times with PBS, and then incubated in X-gal staining solution (5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 1 mM MgCl 2 , 1 mg/ml X-gal in PBS) for 2-4 h at 37°C.
Induction and analysis of apoptosis
To induce LAR expression, cells were trypsinized and washed twice with medium, and plated into tetracycline-free medium at 5 
Protein extraction, immunoprecipitation, and immunoblotting
Metabolic labeling of cells with [ 35 S]methionine and immunoprecipitation was performed as described [2] . Briefly, [ 35 S]methioninelabeled cells were washed with PBS and lysed in cold RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris pH 8.0), and immunoprecipitated with anti-LAR antibody. The proteins were resolved by 6% gels by SDS-PAGE. For immunoblotting, Laemmli sample buffer was added directly to the cells to a final concentration of 10 6 cells/ml. The cell lysates were boiled for 5 min and aliquots equal to approximately 5 × 10 4 cells were subjected to SDS-PAGE (6% or 12% gels) and transferred to nitrocellulose membrane. The membranes were blocked with 5% nonfat dry milk in 10 mM Tris pH 7.5, 100 mM NaCl, 0.1% Tween 20 for 1 h at room temperature, incubated with appropriate primary antibodies for 2 h at room temperature or overnight at 4°C, followed by either secondary antibodies conjugated to alkaline phosphatase or horseradish peroxidase (Promega) for 1 h at room temperature. Proteins were detected with the ProtoBlot Western Blot AP System (Promega) or the ECL kit (Amersham).
Antibodies
Rabbit polyclonal antisera αC-292 and αN-130 are anti-LAR antisera raised against synthetic peptides of the C-terminus and the N-terminus of the LAR protein respectively [2] . and were used at 1:500 dilution. Rabbit polyclonal antisera α−294 was raised against a E. coli-produced full length LAR protein in a similar way as described in [2] and were used at 1:500 dilution. Mouse monoclonal anti-ICE, anti-PARP, and anti-caspase-3 were used at 1:2000 dilution. Mouse monoclonal antibody α-tubulin was purchased from Sigma and used at 1:10000 dilution.
Adhesion assays
Adhesion assays were carried out according to Cary et al. [56] . Briefly, 96-well Immunol-4 microtiter plates (Dynatech Laboratories) were precoated with human plasma fibronectin (Gibco BRL) at various concentrations in DMEM for 60 min at room temperature, washed twice with DMEM, and blocked with 1% BSA for 60 min at 37°C. Cells were initially cultured in regular tissue culture plates with or without tetracycline for 8 h to induce LAR expression. After induction, both LAR+ and LAR-cells were trypsinized, washed once with DMEM containing 0.5 mg/ml soybean trypsin inhibitor (Sigma), twice with DMEM containing 1% BSA, resuspended in DMEM, and then added to the fibronectin coated plates at 5 × 10 4 cells per well. An aliquot of cells at this point was saved for confirming LAR expression. After 30 min incubation at 37°C in a humidified atmosphere containing 5% CO 2 , nonadherent cells were washed twice with PBS, and adherent cells were fixed with 70% ethanol for 20 min. Cells were stained with 5 mg/ml crystal violet in 20% methanol for 10 min and washed 4 times with PBS. Bound stain was extracted with 0.1 M sodium citrate pH 4.2 for 30 min. The optical density (OD) was read at 562 nm. The background OD value from a well without cells was subtracted from the OD value for each well. LAR expression was confirmed by western blot analysis.
